New Delhi: DCGI has approved the use of Virafin in Covid patients. Permitted emergency use of the virus for the treatment of non-severe coronavirus infections. The move comes in the wake of an increase in Covid patients in the country.
Zydus Cadila claims that a single dose of the virus used in hepatitis C patients is effective in treating the disease and accelerating recovery. The experiment was conducted in about 25 centers across the country.
